US Pre-Market SEC Filings Roundup — April 30, 2026

29-04-2026

Veradermics, Incorporated filed Form S-1MEF on April 29, 2026, pursuant to Rule 462(b) to register additional shares of common stock and pre-funded warrants, increasing the aggregate offering price of its public offering by $56,785,800, including underwriters' option to purchase additional shares up to 20% of the maximum. This supplements the prior S-1 (File No. 333-295356), declared effective the same day. The company qualifies as a smaller reporting company and emerging growth company.

• ·I.R.S. Employer Identification Number: 84-3304423
• ·Principal executive offices: 470 James St., New Haven, CT 06513
• ·State of incorporation: Delaware
• ·Primary Standard Industrial Classification Code: 2834
• ·Prior Registration Statement: File No. 333-295356, filed April 27, 2026, effective April 29, 2026

30-04-2026

Ford Motor Company reported Q1 2026 consolidated revenues of $43,253 million, up 6.4% YoY from $40,659 million, with vehicles/parts/accessories rising to $37,644 million (+5%) and used vehicles surging to $1,147 million (+67%). Net income attributable to Ford rose sharply to $2,548 million from $471 million YoY. However, net cash from operating activities declined 64% to $1,316 million from $3,679 million, cash equivalents dropped 24% QoQ to $17,649 million from $23,356 million, and total assets decreased 2.2% QoQ to $282,434 million.

• ·Inventories increased 8.3% QoQ to $16,537 million from $15,285 million.
• ·Dividends declared reduced to $611 million ($0.15 per share) in Q1 2026 from $1,212 million ($0.30 per share) in Q1 2025.
• ·Purchases of common stock $311 million in Q1 2026.
• ·Net cash used in investing activities $771 million in Q1 2026 vs provided $210 million in Q1 2025.

30-04-2026

ImmunityBio, Inc. (IBRX) filed DEFA14A additional proxy materials for its 2026 Annual Meeting on June 9, 2026, at 10:30 A.M. PT virtually, proposing the election of nine director nominees and ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026. The board recommends voting 'FOR' all proposals, with proxy materials available online and voting deadline of June 8, 2026, 11:59 PM ET.

• ·Request paper/email copies of materials by May 26, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com.
• ·Virtual meeting access: www.virtualshareholdermeeting.com/IBRX2026.

30-04-2026

For Q1 2026, Anika Therapeutics reported revenue of $29,612, up 13% YoY from $26,168, driven by a 30% increase in gross profit to $18,997 due to a 8% decline in cost of revenue. However, operating expenses rose 29% YoY to $24,485, primarily from a 38% surge in SG&A to $17,772, resulting in a wider operating loss of $5,488 (up 28% YoY) and net loss of $5,056. Cash and equivalents fell 29% QoQ to $41,020 amid $8,690 in stock repurchases and $4,846 in operating cash use.

• ·Weighted average basic shares outstanding declined to 13,531 from 14,297 YoY.
• ·Stockholders' equity decreased QoQ to $133,901 from $143,465.
• ·Net cash used in operating activities was $4,846 in Q1 2026 vs $130 in Q1 2025.
• ·Company repurchased 775 shares in Q1 2026 vs 241 in Q1 2025.

30-04-2026

Sangamo Therapeutics, Inc. (SGMO) filed a 10-K/A on April 30, 2026, disclosing details of its equity compensation plans. Stockholder-approved plans include 21,072,763 securities to be issued upon exercise of outstanding options, RSUs, and other rights at a weighted average exercise price of $4.53, with 24,118,242 securities remaining available for future issuance. Non-approved plans have 26,000 such securities at $15.00 average price with none remaining available; totals are 21,098,763 securities at $4.55 weighted average price and 24,118,242 remaining.

30-04-2026

Pilgrim's Pride Corporation filed an 8-K on April 30, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, attaching Exhibit 99.1 as supplemental historical financial information and an overview to be used during the Q1 2026 earnings conference call on April 30, 2026. The information is not deemed 'filed' for purposes of Section 18 of the Exchange Act. No specific financial metrics or period-over-period comparisons are disclosed in the filing text itself.

• ·Event date: April 29, 2026
• ·Earnings conference call scheduled for April 30, 2026
• ·Securities: Common Stock, Par Value $0.01 (PPC on Nasdaq Stock Market LLC)

30-04-2026

For the three months ended March 31, 2026, NorthWestern Energy Group reported total revenues of $497,570 up 6.6% YoY from $466,630, with electric revenues increasing 7.9% to $362,054 and gas revenues up 3.3% to $135,516. However, operating expenses rose 12.2% to $383,459 driven by a 31.5% jump in operating and maintenance costs to $74,540, resulting in operating income declining 8.5% to $114,111 and net income dropping 17.6% to $63,456 (EPS $1.03 vs $1.25). Cash from operations improved 3.8% to $159,414, while capex increased to $116,080 from $92,124.

• ·Dividends declared per common share increased to $0.67 from $0.66 YoY.
• ·Total shareholders' equity grew to $2,908,884 from $2,885,740 at Dec 31, 2025.
• ·Interest expense, net, rose to $39,916 from $36,511 YoY.

30-04-2026

Glaukos Corp reported net sales of $150,571 thousand for the three months ended March 31, 2026, up 41.2% YoY from $106,664 thousand, with gross profit increasing 42.3% to $117,232 thousand. However, total operating expenses rose 33.1% YoY to $137,088 thousand, leading to an operating loss of $19,856 thousand (4.0% improvement YoY) but a net loss widening to $19,783 thousand from $18,146 thousand. Cash and equivalents grew to $104,249 thousand QoQ from $90,813 thousand, with net cash used in operations improving to $12,526 thousand from $18,521 thousand YoY.

• ·Short-term investments decreased to $172,436 thousand from $187,947 thousand QoQ.
• ·Inventory slightly declined to $62,384 thousand from $63,564 thousand QoQ.
• ·Total assets remained flat at $893,326 thousand vs $893,487 thousand QoQ.
• ·Stockholders' equity increased to $670,928 thousand from $656,155 thousand QoQ.
• ·Net cash provided by investing activities was $10,504 thousand vs used $36,948 thousand YoY.
• ·Proceeds from exercise of stock options: $19,330 thousand in Q1 2026.

30-04-2026

Demars Financial Group, LLC filed its Form 13F-HR on April 30, 2026, disclosing equity holdings as of March 31, 2026, primarily consisting of sole discretionary positions in a diversified portfolio of individual stocks and ETFs. Key holdings include Apple Inc., Berkshire Hathaway Inc. Del Cl B, BWX Technologies Inc., Chubb Ltd., and various iShares and SPDR ETFs. No prior period comparisons or performance metrics are provided in the filing.

• ·Filing CIK: 0001723115
• ·State of Incorporation: WA
• ·Business Address: 420 N EVERGREEN RD, STE 300, SPOKANE VALLEY, WA 99216
• ·All positions reported as SOLE investment discretion

30-04-2026

PDF Solutions, Inc. (PDFS) filed a DEFA14A Definitive Additional Materials proxy statement on April 30, 2026, pursuant to Section 14(A) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No substantive business updates, financial metrics, or voting items are detailed in the provided header content.

• ·Filing Type: DEFA14A (Schedule 14A Proxy Statement)
• ·Subcategory: Definitive Additional Materials
• ·Payment of Filing Fee: No fee required

30-04-2026

SwitchPoint Financial Planning, LLC filed its 13F-HR report disclosing holdings as of March 31, 2026, across 102 positions with a total market value of $147,485,022. The portfolio is heavily weighted toward Dimensional ETF Trust funds (e.g., Emerging Markets Core, International Core Equity), Vanguard index funds and ETFs, and individual stocks including Alphabet Inc (Classes A and C), Apple Inc, Microsoft Corp, Amazon.com Inc, and Berkshire Hathaway. No period-over-period changes are provided in the filing.

• ·Filing date: April 30, 2026
• ·Report period end: March 31, 2026
• ·Business address: 2901 W Bluegrass Blvd, Suite 200-26, Lehi, UT 84043
• ·SEC file number: 028-24924

30-04-2026

Ford Motor Credit Co LLC's total assets decreased 2.4% quarter-over-quarter to $158,541M as of March 31, 2026 from $162,453M at December 31, 2025, driven by lower finance receivables net ($117,049M, down 2.3%). Net income for Q1 2026 rose 59% YoY to $675M from $424M in Q1 2025, with cash from operating activities up 61% to $1,294M; however, shareholder’s interest fell 2.3% to $14,467M due to a $950M distribution, debt decreased 2.7% to $137,531M, and provision for credit losses increased 23% YoY to $172M.

• ·Allowance for credit losses increased to $937M from $911M QoQ.
• ·Distributions declared $950M in Q1 2026 vs $200M in Q1 2025.
• ·Net cash decrease in cash, cash equivalents, and restricted cash was $1,340M in Q1 2026 vs $1,816M decrease in Q1 2025.

30-04-2026

Lipe & Dalton filed a 13F-HR on April 30, 2026, disclosing $191.04 million in total equity holdings across 92 positions as of March 31, 2026, all held on a sole discretionary basis. Top holdings include Apple Inc. at $16.643 million (65,579 shares), Goldman Sachs Group Inc. at $12.132 million (14,340 shares), and Brookfield Corp Cl A at $6.825 million (168,636 shares). No period-over-period changes or performance metrics are provided in the filing.

• ·Filing covers holdings as of 03-31-2026 with no other voting authority or shared discretion positions.
• ·Firm address: 103 East Water Street, Suite 305, Syracuse, NY 13202.

30-04-2026

Vivos Therapeutics, Inc. filed an amended S-3 shelf registration statement to potentially issue securities, amid a business pivot from dentist training to a medical-provider focused model including the June 2025 acquisition of Sleep Center of Nevada (SCN) and Detroit-area MSO/DSO setups. The company highlights treatment of approximately 75,000 patients worldwide with its Vivos Method oral appliances, showing effectiveness in 80% of compliant OSA cases and AHI improvements in 88-91% of patients, but notes challenges like ending its Rebis Health alliance, ongoing operating losses, capital needs, and going concern risks tied to Nasdaq compliance. This evolution aims to scale via Sleep and Airway Medicine Centers (SAMC) but underscores reliance on future capital raises.

• ·Treatment course typically 9-12 months, with few reported relapses out of 75,000 patients.
• ·No longer offering Guided Growth and Development to unaffiliated dentists as of April 2026.
• ·SCN acquisition in June 2025 included sleep testing, diagnostics, and treatment centers.
• ·Rebis Health alliance ended due to unmet revenue expectations.

30-04-2026

News Corporation disclosed updates provided to the Australian Securities Exchange (ASX) regarding its ongoing stock repurchase program, which authorizes up to $1 billion in aggregate repurchases of Class A and Class B common stock. The disclosures, attached as Exhibits 99.1 and 99.2, are made daily if transactions occur under the program. No specific repurchase volumes or amounts were detailed in the filing itself.

• ·Date of earliest event reported: April 29, 2026
• ·Filing Date: April 30, 2026
• ·Class A Common Stock trading symbol: NWSA (Nasdaq Global Select Market)
• ·Class B Common Stock trading symbol: NWS (Nasdaq Global Select Market)

30-04-2026

First Northern Community Bancorp reported first quarter 2026 net income of $5.9 million ($0.36 per diluted share), up 60.9% YoY from $3.7 million ($0.22 per diluted share), fueled by net interest income growth of 7.91% to $17.2 million, non-interest income up 19.75% to $1.7 million, and non-interest expense down 4.81% to $11.0 million. Total assets reached $1.92 billion (up 2.6% YoY), net loans $1.06 billion (up 2.3% YoY, driven by commercial but offset by declines in CRE, agriculture, residential, and consumer), and deposits $1.69 billion (up 1.2% YoY); however, QoQ net income declined 1.2% to $5.9 million from $6.0 million, net interest income fell 3.0%, and cash equivalents dropped 4.1%. The company issued a 5% stock dividend, announced a repurchase of up to 6% of shares, and uplisted to Nasdaq Capital Market post-quarter.

• ·ROAA 1.24% (up YoY from 0.79%, flat QoQ from 1.23%)
• ·ROAE 11.21% (down QoQ from 11.40%, up YoY from 8.23%)
• ·Total risk-based capital ratio exceeds 10%, with Total capital ratio 19.1%
• ·Book value per share $13.03 (up from $12.92 at Dec 31 2025 and $11.25 at Mar 31 2025)
• ·Provision for credit losses $300k (vs $850k YoY and reversal of $850k QoQ)
• ·Cost of funds 0.90% (up slightly YoY from 0.86%)

30-04-2026

Beam Wealth Advisors, Inc. filed its 13F-HR on April 30, 2026, reporting holdings as of March 31, 2026, across 108 securities with a total market value of $401,731,792. The portfolio is diversified with a heavy emphasis on ETFs, including top positions in iShares Core S&P 500 ETF ($73,425,678), VanEck Real Assets ETF ($28,767,586), and iShares MSCI Emerging China ETF ($22,840,464), alongside individual stocks such as Apple Inc. ($6,166,783) and NVIDIA Corporation ($8,609,457). All reported positions are held as sole discretionary shares with no indications of changes, shared voting, or performance rights.

• ·All 108 positions reported as SH SOLE with zero shared voting or performance rights.
• ·Holdings include cryptocurrency-related ETFs such as Grayscale Ethereum Staking ($354,254), Bitwise Ethereum ETF ($3,250,140), and Fidelity Ethereum Fund ($1,818,606).
• ·Former company name: BEAM Asset Management, LLC (changed 2020-02-13).
• ·Adviser CRD: 109867, SEC file: 801-60334.

30-04-2026

QDRO Acquisition Corp., a SPAC, completed its IPO in Q1 2026, raising net proceeds of $196M and depositing $200M into the Trust Account, resulting in total assets of $201.3M as of March 31, 2026, up dramatically from $0.4M at year-end 2025. However, the company reported a net loss of $145,685 for the quarter due to $165K in general and administrative costs, with shareholders' deficit widening to $7.1M from $66K amid accretion of $15.2M related to redeemable shares.

• ·IPO involved sale of 20,000,000 Units; 750,000 founder shares forfeited.
• ·Promissory note – related party repaid in full ($240,315 outstanding at Dec 31, 2025).
• ·Deferred offering costs cleared post-IPO.
• ·Trading symbols: QADRU (Units), QADR (Class A Shares), QADRW (Warrants) on NASDAQ.

30-04-2026

CIMPRESS plc (CMPR) filed an 8-K on April 30, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing Q3 FY26 quarterly earnings. Details are contained in Exhibit 99.1 (q3_fy26quarterlyearnings.htm). No specific financial metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Filing Type: 8-K
• ·Items Reported: 2.02, 9.01
• ·Subcategory: Unregistered Securities Sale (noted but not detailed in content)
• ·Exhibit: EX-99.1 (Q3 FY26 Quarterly Earnings HTML)

30-04-2026

Bonk, Inc. (NASDAQ:BNKK) appointed founder Mitchell Rudy (Nom) as President, while he retains his Board seat, to drive a three-pillar mandate: path to profitability via high-margin digital revenue, targeted accumulation to 5% ownership of BONK digital asset supply, and direct business incubation. The company is expanding into Real-World Asset (RWA) capabilities, prediction markets, and social betting verticals, building on partnerships like dYdX for BONK.trade and addressing the gap between market cap and its $30 million interest in BONK.fun. CEO Jarrett Boon highlighted Rudy's role in executing the digital pivot with precision.

• ·Announcement date: April 29, 2026
• ·Company location: Scottsdale, AZ
• ·Operates revenue-generating assets in Solana ecosystem

30-04-2026

Titan International reported Q1 2026 net sales of $505.1 million, up 2.9% YoY from $490.7 million, driven by 11.3% growth in the Earthmoving/Construction (EMC) segment, modest 0.3% growth in Agricultural, and a 1.6% decline in Consumer. Gross margin improved slightly to 14.1% from 14.0%, and Adjusted EBITDA rose to $31.4 million from $30.8 million. However, the company recorded an operating loss of $13.8 million versus prior year operating income of $11.8 million, primarily due to $2 million in restructuring charges and $23 million in non-cash impairment from the Jackson, Tennessee plant closure.

• ·Q2 2026 guidance: sales $470-490 million, Adjusted EBITDA $25-30 million.
• ·FY 2026 guidance maintained: sales $1.85-1.95 billion, Adjusted EBITDA $105-115 million.
• ·Cash flows used for operating activities: $46.5 million in Q1 2026.

30-04-2026

Hippo Holdings Inc. reported Q1 2026 net income of $7.1 million ($0.27 per diluted share) versus a $47.7 million net loss in Q1 2025, with adjusted net income of $17.2 million ($0.65 per diluted share) versus a $35.1 million adjusted net loss; gross written premium surged 58% YoY to $332.4 million, revenue grew 10% to $121.5 million, and combined ratio improved 60 points to 99.5%. However, net written premium grew only 1% to $101.4 million due to a drop in net retention to 31% from 48%, and the Renters line contracted $26 million YoY amid a one-time unearned premium adjustment. Updated FY2026 guidance raised gross written premium to $1.45-1.525 billion while maintaining combined ratio at 103-105%.

• ·Net earned premium increased 13% YoY to $98.9M.
• ·Expense ratio improved 2 pts to 51.5%.
• ·FY2026 guidance: Net Written Premium $520-550M (prior $500-540M), Adjusted Net Income $48-56M (prior $45-55M).
• ·Cash and cash equivalents $275.4M at Mar 31 2026 (up from $218.3M at year-end).
• ·Catastrophe losses $4.3M (4.3% of NEP) vs $53.4M (61.2%) prior year.

30-04-2026

On April 26, 2026, Regional Health Properties, Inc. appointed Marlie Davis, CPA, MBA, as Chief Financial Officer effective May 1, 2026; she brings over 20 years of finance, accounting, audit, and real estate investment experience from roles at Hatteras Sky and other firms. Compensation includes an initial annual base salary of $265,000, target bonus of $100,000, 35,000 restricted stock units, and options for 35,000 shares. Separately, Director Christopher Winkle resigned effective May 31, 2026, not due to any disagreement with the company.

• ·Ms. Davis is age 55, holds an MBA from Utica College and BBA in Accounting from University of Central Florida.
• ·No arrangements, family relationships, or material interests under Item 404(a) for Ms. Davis.
• ·Employment is at-will with nine months severance upon termination without cause.

30-04-2026

Southside Bancshares reported Q1 2026 net income of $23.3 million, up 8.1% YoY from $21.5 million, with diluted EPS of $0.78 (up 9.9%) and linked quarter loan growth of 2.7% to $4.95 billion. Net interest income rose to $57.7 million (up 7.1% YoY and 0.8% linked), with tax-equivalent NIM expanding 3bps linked to 3.01%, while nonperforming assets fell sharply to 0.11% of total assets. However, noninterest expense increased 9.4% YoY and 8.3% linked quarter to $40.6 million, deposits grew only 0.1% linked quarter amid declines in retail (-1.6%) and public fund deposits (-1.7%), and efficiency ratio worsened to 56.44% from 53.85% linked quarter.

• ·Provision for credit losses on loans: $1.0 million in Q1 2026 (vs $0.6 million in Q4 2025)
• ·Q1 cash dividend: $0.36 per share, paid March 5, 2026
• ·No common stock repurchases under the Plan in Q1 2026; 0.8 million shares remain authorized
• ·Estimated uninsured deposits: 38.4% of total deposits (21.9% excluding affiliate and public fund deposits)
• ·Noninterest-bearing deposits: 20.0% of total deposits

30-04-2026

Xcel Energy Inc. and its subsidiaries, including Northern States Power Company (Minnesota and Wisconsin), Public Service Company of Colorado, and Southwestern Public Service Company, filed a Form 8-K on April 30, 2026, announcing the release of first quarter 2026 earnings results under Item 2.02. The earnings release is furnished as Exhibit 99.01. The filing was signed by Brian J. Van Abel, Executive Vice President and Chief Financial Officer.

30-04-2026

GOLD RESOURCE CORP's Pay Versus Performance table discloses negative TSR with the value of a $100 investment falling to $15 in 2024 from $25 in 2023 before partially recovering to $54 in 2025 (+260% YoY), alongside persistent net losses that narrowed to ($6,459) thousand in 2025 from ($56,501) thousand in 2024 (88.6% improvement) but remained negative versus ($24,144) thousand in 2023. PEO summary compensation declined 7.4% YoY to $757,218 in 2025, while actually paid compensation rose sharply to $1,197,994 (+90.9% YoY); average non-PEO NEO summary compensation was flat to slightly up at $468,177. The disclosure notes that U.S. GAAP net income did not influence NEO compensation, with a prior material weakness identified in controls over Back Forty Project liabilities.

• ·U.S. GAAP net income was not a performance metric in any compensation programs and did not affect NEO compensation.
• ·2023 net income adjusted for restatement due to material weakness in controls over financial reporting related to Back Forty Project liabilities; refer to 2024 Annual Report.

30-04-2026

Total fees to the independent auditor declined 2.4% YoY to $9,672,480 in 2025 from $9,904,000 in 2024, driven by a 5.1% drop in audit fees to $8,514,570 despite a 21.2% rise in tax fees to $1,131,960. The 2020 incentive plan expired on May 21, 2025, leaving 76,646 QVCGA options and 492,473 RSUs/DSUs outstanding, with none of the 478,989 performance-based RSUs earned. Assumed HSN awards from the 2017 acquisition remain minimal, totaling 13,074 QVCGA options at a $613.70 weighted average exercise price.

• ·Audit-related fees in 2025: $22,450 (none in 2024).
• ·All other fees in 2025: $3,500 (none in 2024).
• ·Assumed HSN awards include 69 QVCGA and 104 QVCGP DSUs under 2008 plan, 110 QVCGA and 165 QVCGP DSUs under 2017 plan.
• ·May 2025 reverse stock split adjusted Ms. Dias’s awards.

30-04-2026

Amazon reported strong Q1 2026 results with total net sales increasing 16.6% YoY to $181,519M, driven by 11.5% growth in net product sales to $71,304M and 20.2% in net service sales to $110,215M; net income surged 76.7% YoY to $30,255M with diluted EPS at $2.78. Operating cash flow rose 53% YoY to $26,032M, though investing cash flow deteriorated to -$64,212M due to sharply higher capex of $44,203M (up 76.7% YoY). Total assets grew to $916,630M, but inventories declined slightly to $36,534M.

• ·Long-term debt increased to $119,074M from $65,648M as of Dec 31 2025.
• ·TTM net cash from operating activities reached $148,531M, up from $113,903M.
• ·Diluted shares used: 10,874M in Q1 2026 vs 10,793M in Q1 2025.

30-04-2026

RF Acquisition Corp III, a SPAC, reported net income of $725,986 for the three months ended March 31, 2026 and $673,033 for the six months ended, driven by $825,232 in other income from interest on the Trust Account ($403,232) and fair value changes ($422,000), despite operating losses of $99,246 and $152,199 respectively from general and administrative costs. The company completed its IPO, funding the Trust Account to $100,403,232 (10,000,000 shares at $10.04 redemption value) and increasing total assets to $101.4M from $113K at September 30, 2025, with shareholders' equity rising to $899K. Cash stood at $933K post-IPO, but net cash used in operations was $168K for the six months.

• ·Net cash used in operating activities for six months: $168,184
• ·Promissory note – related party repaid: $159,374 (six months)
• ·Accretion of carrying value to redemption value: $5,701,876
• ·Ordinary shares subject to possible redemption: 10,000,000 shares at $10.04 per share

30-04-2026

KLA Corp reported strong Q3 FY2026 results with total revenues of $3,415.1 million, up 11.5% YoY from $3,063.0 million, driven by product revenue growth of 10.3% to $2,640.3 million and service revenue up 15.8% to $774.8 million; net income rose 10.2% YoY to $1,201.0 million. For the nine months ended March 31, 2026, revenues increased 10.5% YoY to $9,921.9 million and net income surged 21.3% to $3,467.7 million. However, cash and cash equivalents declined 14.0% to $1,787.0 million from $2,078.9 million at June 30, 2025, reflecting significant share repurchases of $1.72 billion and dividend payments of $752.5 million.

• ·Operating cash flow for 9M FY2026: $3,236.6 million, up from $2,916.9 million prior year.
• ·Capital expenditures for 9M FY2026: $286.7 million.
• ·Inventories increased to $3,437.0 million from $3,212.1 million at Jun 30, 2025 (+7%).
• ·Long-term debt stable at $5,887.1 million.
• ·Net cash used in investing activities 9M FY2026: $1,017.0 million.

30-04-2026

Benchmark Electronics Inc reported Q1 2026 sales of $677,280 thousand, up 7.2% YoY from $631,764 thousand, with gross profit rising 9.6% to $69,234 thousand and net income surging 257% to $13,023 thousand, aided by lower restructuring charges of $3,747 thousand versus $11,417 thousand. Operating cash flow improved 49.3% to $47,028 thousand YoY. However, inventories increased 5.3% QoQ to $507,447 thousand, shareholders' equity declined 0.3% QoQ to $1,096,501 thousand, and advance payments from customers fell to $110,966 thousand from $115,545 thousand QoQ.

• ·Accounts receivable decreased to $375,902 thousand from $391,101 thousand QoQ.
• ·Accounts payable increased to $451,146 thousand from $403,222 thousand QoQ.
• ·Dividends declared $6,101 thousand in Q1 2026.
• ·Share repurchases totaled $5,799 thousand in Q1 2026.
• ·Goodwill stable at $192,116 thousand, allocated $154,014 thousand to Americas and $38,102 thousand to Asia.

30-04-2026

Bausch Health Companies Inc. reported Q1 2026 revenues of $2,524 up 11.7% YoY from $2,259, primarily driven by product sales growth of 12.3% to $2,500. However, a $1,426 goodwill impairment resulted in an operating loss of $950 versus prior year income of $276, and net loss attributable to the company widened to $1,423 from $58. Cash provided by operating activities edged up 9% to $230 while total assets declined to $24,498 from $26,366 at year-end.

• ·Goodwill decreased to $9,807 from $11,271 at Dec 31 2025 due to $1,426 impairment.
• ·Shareholders' deficit widened to $(2,059) from $(554) at Dec 31 2025.
• ·Long-term debt (current + non-current) totaled $20,764 at Mar 31 2026 versus $20,817 at Dec 31 2025.
• ·Small acquisition with $87 fair value of consideration transferred and $65 identifiable net assets.

30-04-2026

Canadian Pacific Kansas City Ltd (CP) reported Q1 2026 total revenues of $3,701 million, down 2% YoY from $3,795 million, with freight revenues declining 3% to $3,628 million as most segments decreased (e.g., Forest products -17%, Coal -12%) while Grain grew 11% to $871 million. Operating income fell 4% to $1,258 million and net income dropped 7% to $845 million (EPS $0.94 vs $0.98), though cash from operations was $976 million and the company ramped up share repurchases to $680 million from $347 million. Comprehensive income rose sharply to $1,398 million from $881 million, boosted by a $538 million foreign currency translation gain.

• ·Weighted-average basic shares decreased to 896.8 million from 933.2 million YoY due to repurchases.
• ·Dividends declared per share increased to $0.228 from $0.190.
• ·Additions to properties decreased to $664 million from $711 million.
• ·Long-term debt increased to $21,883 million as at March 31, 2026 from $19,948 million at Dec 31, 2025.

30-04-2026

Acadia Healthcare reported Q1 2026 revenue of $828,802 thousand, up 7.6% YoY from $770,505 thousand, driven by 14.2% growth in acute inpatient psychiatric facilities to $470,653 thousand and 6.3% in residential treatment centers, while specialty treatment facilities declined 6.5% to $128,116 thousand and comprehensive treatment centers grew modestly 2.5% YoY. However, net income attributable to ACHC fell 51% to $4,105 thousand from $8,374 thousand, with EPS dropping to $0.05 from $0.09, due to higher legal settlements expense ($13,751 thousand vs $3,504 thousand), professional fees, and interest expense. Operating cash flow improved sharply to $61,531 thousand from $11,477 thousand.

• ·Medicaid revenue increased to 60.7% of total ($503,406 thousand) from 55.9% ($430,814 thousand), while commercial payer mix declined to 22.4% ($185,926 thousand) from 25.0%.
• ·Accounts receivable, net increased QoQ to $471,752 thousand from $440,604 thousand as of December 31, 2025.
• ·Capital expenditures were $76,564 thousand in Q1 2026, down significantly from $174,631 thousand in Q1 2025.

30-04-2026

Chipotle Mexican Grill reported Q1 2026 total revenue of $3,088,242 up 7.4% YoY from $2,875,253, primarily driven by 7.5% growth in food and beverage revenue to $3,072,730, while delivery service revenue remained nearly flat at $15,512. However, income from operations declined 17.1% to $397,063 due to sharp increases in labor (12.1%), food costs (9.0%), and other operating costs (15.8%), resulting in net income of $302,824, down 21.7% YoY. The company repurchased $755,256 in common stock, contributing to a drop in shareholders' equity to $2,407,635 and cash equivalents to $246,636.

• ·Net cash used in financing activities: $747,490 in Q1 2026 vs $585,174 in Q1 2025 due to higher stock repurchases.
• ·Operating cash flow increased 17% YoY to $651,350.
• ·Capital expenditures (purchases of leasehold improvements, property and equipment): $180,332 in Q1 2026 vs $144,810 in Q1 2025.
• ·Chipotle Rewards liability ending balance: $67,340 as of Mar 31 2026.

30-04-2026

Moelis & Co reported revenues of $319,780 for Q1 2026, up 4.2% YoY from $306,593, with operating income increasing 9.7% to $40,496. However, net income attributable to the company declined 23.5% to $38,433 from $50,268, resulting in diluted EPS of $0.48 versus $0.64 YoY. Total assets fell to $1,289,194 from $1,740,685 QoQ, driven by sharp drops in cash and investments, while operating cash flow deteriorated to negative $278,798 from negative $165,480 YoY.

• ·Compensation payable decreased to $64,752 from $439,394 QoQ.
• ·Treasury stock purchases of $117,270 in Q1 2026.
• ·Dividends declared at $0.65 per share of Class A common stock.

30-04-2026

Southern Power Company's 10-Q filing dated April 30, 2026 covers the quarter ended March 31, 2026, providing metadata including filer status as a Large Accelerated Filer, shares outstanding of 1,000 (par value $0.01 per share), and listings of junior subordinated notes and senior notes traded on NYSE. The document includes a table of contents pointing to unaudited financial statements and MD&A starting on page 9, along with an extensive glossary of terms related to Southern Company subsidiaries and operations. No specific quarterly financial performance metrics such as revenue, earnings, or period-over-period comparisons are detailed in the provided excerpt.

• ·Southern Power Company designated as Large Accelerated Filer.
• ·Financial statements (unaudited) begin on page 9; MD&A on page 83.
• ·Glossary includes terms like AFUDC, ARO, CWIP, HLBV, IRA, PTC, and references to Vogtle Owners (Georgia Power, OPC, MEAG Power, Dalton).

30-04-2026

Alphabet Inc. reported Q1 2026 revenues of $109,896M, up 21.8% YoY from $90,234M, with net income surging 81.1% YoY to $62,578M driven by strong Google Cloud growth of 63.4% to $20,028M and Google advertising up 15.5% to $77,253M. However, Google Network revenues declined 3.9% YoY to $6,971M, Other Bets fell 8.7% to $411M, and the company recorded hedging losses of $180M versus gains of $260M prior year. Total assets expanded to $703,919M, bolstered by acquisitions totaling $33,621M net.

• ·Operating cash flow increased 26.7% YoY to $45,790M.
• ·No stock repurchases in Q1 2026 versus $15,068M in Q1 2025.
• ·Long-term debt rose to $77,501M from $46,547M as of Dec 31, 2025.
• ·Goodwill increased to $57,774M from $33,380M, reflecting acquisitions.
• ·Dividends declared at $0.21 per share, up from $0.20 prior year.
• ·Net cash used in investing activities widened to $63,389M from $16,194M.

30-04-2026

CRH reported Q1 2026 total revenues of $7,370M, up 9.1% YoY from $6,756M, with strong growth in Americas Materials Solutions (+21.5% to $2,724M) and International Solutions (+5.3% to $2,978M), while Americas Building Solutions declined slightly (-0.8% to $1,668M). However, net loss widened to $(180)M from $(98)M YoY, resulting in comprehensive loss attributable to CRH of $(272)M versus $105M income last year, amid higher impairments and operating cash use of $(616)M (improved from $(659)M). Cash and equivalents fell to $3,240M from $4,096M at year-end, with total assets stable at $58,167M.

• ·Equity method investments decreased to $487M from $502M (Dec 2025) and $732M (Mar 2025).
• ·Long-term debt $16,071M at Mar 31 2026, down slightly from $16,478M (Dec 2025).
• ·Capex purchases of PP&E and intangibles $601M in Q1 2026 vs $645M prior year.
• ·Share repurchases $332M in Q1 2026.

30-04-2026

Brunswick Corporation announced its financial results for the first quarter 2026 on April 30, 2026, via a news release attached as Exhibit 99.1. The release utilizes non-GAAP measures including adjusted diluted EPS (excluding purchase accounting amortization, restructuring charges, and other items), adjusted operating earnings, and free cash flow to reflect ongoing business performance. No specific financial figures or period-over-period comparisons are detailed in the filing itself.

30-04-2026

NXT Energy Solutions Inc. reported SFD®-related revenue of $16,351,286 for YE 2025, surging from $644,294 in YE 2024, while net loss improved to $2,317,149 ($0.02 per share) from $9,077,795 ($0.12 per share), aided by full acquisition of SFD® rights, new contracts in South Asia and Africa, and a $2,000,000 strategic investment. Cash and short-term investments reached $3,920,213 at year-end, with net working capital up 179% to $5.26 million. However, the company noted its cash position is insufficient for obligations beyond the audit date, G&A expenses rose 7% or $0.28 million YoY, and ongoing going concern risks persist amid lease and debt obligations.

• ·Lease liabilities decreased to $1,573,302 at YE 2025 from $2,301,542 at YE 2024.
• ·Long-term debt reduced to $601,852 at YE 2025 from $712,963 at YE 2024.
• ·Cash flow used in operating activities YE 2024: $3.97 million.
• ·New CEO appointment: Mr. Gerry Sheehan on April 20, 2026; Mr. Bruce G. Wilcox retired.
• ·South Asia SFD® survey contract announced April 8, 2026.

30-04-2026

The Cigna Group reported strong Q1 2026 results with total revenues up 5% YoY to $68.5 billion and adjusted income from operations up 12% YoY to $2.1 billion ($7.79 per share), driven by growth in Evernorth Health Services and Cigna Healthcare, while raising full-year 2026 adjusted income outlook to at least $30.35 per share. However, Pharmacy Benefit Services adjusted income declined 28% YoY, Cigna Healthcare revenues fell 21% YoY due to the HCSC transaction (up 8% excluding it), and total customer relationships decreased 2% QoQ to 185.5 million. The adjusted SG&A expense ratio improved to 4.8% from 5.8% YoY, reflecting efficiency gains.

• ·Evernorth Health Services adjusted revenues up 9% YoY to $58.4 billion; adjusted income from operations pre-tax up 2% YoY to $1.47 billion (margin 2.5%).
• ·Debt-to-capitalization ratio 42.3% at Mar 31 2026 (down from 43.0% at Dec 31 2025).
• ·2026 outlook: Evernorth adjusted income from operations pre-tax at least $6.9 billion; Cigna Healthcare at least $4.525 billion; MCR 83.7% to 84.7%.
• ·Corporate adjusted loss from operations pre-tax $377 million in Q1 2026 (vs $411 million Q1 2025).

30-04-2026

Archimedes Tech SPAC Partners II Co. (ATII) filed a Form 425 on April 30, 2026, furnishing a transcript of a conference call held on April 28, 2026, where management teams from Forge Nano, Inc. and ATII reviewed their proposed business combination under a Merger Agreement dated April 20, 2026. The filing emphasizes that additional details will be in an upcoming Form S-4 Registration Statement and highlights extensive risks including shareholder approval failure, high redemptions, operational disruptions, and competitive pressures that could prevent closing or realization of benefits. Investors are urged to review SEC filings for complete information.

• ·Merger Agreement dated April 20, 2026, involving ATII, Pubco, Merger Sub I, Merger Sub II, and Forge Nano.
• ·ATII's Annual Report on Form 10-K for fiscal year ended December 31, 2025, filed March 4, 2026.
• ·Securities: ATIIU (Units), ATII (Ordinary Shares), ATIIW (Warrants) on Nasdaq.

30-04-2026

Lanvin Group Holdings Ltd filed its 20-F Annual Report on April 30, 2026, featuring forward-looking information disclaimers. The report highlights key risks such as potential impacts from health epidemics like COVID-19, challenges in safeguarding brand value and responding to customer preferences, inventory management issues leading to excess or shortages, IP protection failures, and reliance on dividends from subsidiaries which could limit cash flows if restricted. No financial metrics or performance data are detailed in the provided section.

30-04-2026

Sound Group Inc. (SOGP) reported a strong cash flow turnaround for the year ended December 31, 2025, with net cash from operating activities swinging to RMB 280,031 thousand (US$ 40,044 thousand) from RMB (26,469) thousand in 2024, driving a net cash increase of RMB 206,739 thousand and year-end cash, cash equivalents, and restricted cash of RMB 659,902 thousand (US$ 94,365 thousand). However, accounts receivable declined 10% to RMB 972 thousand from RMB 1,082 thousand as of December 31, 2024, cash used in investing activities was RMB 3,801 thousand (less than 2024's RMB 11,974 thousand), while financing activities saw a larger outflow of RMB 66,201 thousand compared to RMB 2,994 thousand in 2024. Lease obligations totaled RMB 31,844 thousand.

• ·Valuation methodology includes WACC derived from risk-free rate, industry risk, equity risk premium, company size, and non-systematic risks, using comparable companies in audio online business and AI application industries.
• ·DLOM quantified using Finnerty put options model.
• ·Hypothetical taxation scenario: 25% statutory tax rate, 10% withholding tax on dividends to foreign parent, resulting in 67.5% net distribution to shareholders.